These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 28209617)

  • 1. Loss of NDRG2 Expression Confers Oral Squamous Cell Carcinoma with Enhanced Metastatic Potential.
    Tamura T; Ichikawa T; Nakahata S; Kondo Y; Tagawa Y; Yamamoto K; Nagai K; Baba T; Yamaguchi R; Futakuchi M; Yamashita Y; Morishita K
    Cancer Res; 2017 May; 77(9):2363-2374. PubMed ID: 28209617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NDRG2 is a candidate tumor-suppressor for oral squamous-cell carcinoma.
    Furuta H; Kondo Y; Nakahata S; Hamasaki M; Sakoda S; Morishita K
    Biochem Biophys Res Commun; 2010 Jan; 391(4):1785-91. PubMed ID: 20045673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of NDRG2 enhanced activation of the NF-κB pathway by PTEN and NIK phosphorylation for ATL and other cancer development.
    Ichikawa T; Nakahata S; Fujii M; Iha H; Morishita K
    Sci Rep; 2015 Aug; 5():12841. PubMed ID: 26269411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational analysis of PTEN/PIK3CA/AKT pathway in oral squamous cell carcinoma.
    Cohen Y; Goldenberg-Cohen N; Shalmon B; Shani T; Oren S; Amariglio N; Dratviman-Storobinsky O; Shnaiderman-Shapiro A; Yahalom R; Kaplan I; Hirshberg A
    Oral Oncol; 2011 Oct; 47(10):946-50. PubMed ID: 21824802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of miR-204 enables oral squamous cell carcinomas to promote cancer stemness, EMT traits, and lymph node metastasis.
    Yu CC; Chen PN; Peng CY; Yu CH; Chou MY
    Oncotarget; 2016 Apr; 7(15):20180-92. PubMed ID: 26933999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of FAP suppresses cell proliferation and metastasis through PTEN/PI3K/AKT and Ras-ERK signaling in oral squamous cell carcinoma.
    Wang H; Wu Q; Liu Z; Luo X; Fan Y; Liu Y; Zhang Y; Hua S; Fu Q; Zhao M; Chen Y; Fang W; Lv X
    Cell Death Dis; 2014 Apr; 5(4):e1155. PubMed ID: 24722280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of NDRG2 expression activates PI3K-AKT signalling via PTEN phosphorylation in ATLL and other cancers.
    Nakahata S; Ichikawa T; Maneesaay P; Saito Y; Nagai K; Tamura T; Manachai N; Yamakawa N; Hamasaki M; Kitabayashi I; Arai Y; Kanai Y; Taki T; Abe T; Kiyonari H; Shimoda K; Ohshima K; Horii A; Shima H; Taniwaki M; Yamaguchi R; Morishita K
    Nat Commun; 2014 Feb; 5():3393. PubMed ID: 24569712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcutaneous carbon dioxide suppresses epithelial-mesenchymal transition in oral squamous cell carcinoma.
    Iwata E; Hasegawa T; Takeda D; Ueha T; Kawamoto T; Akisue T; Sakai Y; Komori T
    Int J Oncol; 2016 Apr; 48(4):1493-8. PubMed ID: 26846904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long Non Coding RNA MALAT1 Promotes Tumor Growth and Metastasis by inducing Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma.
    Zhou X; Liu S; Cai G; Kong L; Zhang T; Ren Y; Wu Y; Mei M; Zhang L; Wang X
    Sci Rep; 2015 Nov; 5():15972. PubMed ID: 26522444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing PFKP inhibits starvation-induced autophagy, glycolysis, and epithelial mesenchymal transition in oral squamous cell carcinoma.
    Chen G; Liu H; Zhang Y; Liang J; Zhu Y; Zhang M; Yu D; Wang C; Hou J
    Exp Cell Res; 2018 Sep; 370(1):46-57. PubMed ID: 29894707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TROP2 increases growth and metastasis of human oral squamous cell carcinoma through activation of the PI3K/Akt signaling pathway.
    Tang G; Tang Q; Jia L; Chen Y; Lin L; Kuai X; Gong A; Feng Z
    Int J Mol Med; 2019 Dec; 44(6):2161-2170. PubMed ID: 31638186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of homeodomain-interacting protein kinase 2 promotes oral squamous cell carcinoma metastasis through inhibition of P53-dependent E-cadherin expression.
    Zheng X; Pan Y; Chen X; Xia S; Hu Y; Zhou Y; Zhang J
    Cancer Sci; 2021 Jan; 112(1):117-132. PubMed ID: 33063904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoprevention by Quercetin of Oral Squamous Cell Carcinoma by Suppression of the NF-κB Signaling Pathway in DMBA-treated Hamsters.
    Zhang W; Yin G; Dai J; Sun YU; Hoffman RM; Yang Z; Fan Y
    Anticancer Res; 2017 Aug; 37(8):4041-4049. PubMed ID: 28739686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of SIRT1 in regulation of epithelial-to-mesenchymal transition in oral squamous cell carcinoma metastasis.
    Chen IC; Chiang WF; Huang HH; Chen PF; Shen YY; Chiang HC
    Mol Cancer; 2014 Nov; 13():254. PubMed ID: 25424420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTENp1, a natural sponge of miR-21, mediates PTEN expression to inhibit the proliferation of oral squamous cell carcinoma.
    Gao L; Ren W; Zhang L; Li S; Kong X; Zhang H; Dong J; Cai G; Jin C; Zheng D; Zhi K
    Mol Carcinog; 2017 Apr; 56(4):1322-1334. PubMed ID: 27862321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IFIT1 and IFIT3 promote oral squamous cell carcinoma metastasis and contribute to the anti-tumor effect of gefitinib via enhancing p-EGFR recycling.
    Pidugu VK; Wu MM; Yen AH; Pidugu HB; Chang KW; Liu CJ; Lee TC
    Oncogene; 2019 Apr; 38(17):3232-3247. PubMed ID: 30626937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stathmin guides personalized therapy in oral squamous cell carcinoma.
    Ju WT; Ma HL; Zhao TC; Liang SY; Zhu DW; Wang LZ; Li J; Zhang ZY; Zhou G; Zhong LP
    Cancer Sci; 2020 Apr; 111(4):1303-1313. PubMed ID: 31994271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour cell-derived WNT5B modulates in vitro lymphangiogenesis via induction of partial endothelial-mesenchymal transition of lymphatic endothelial cells.
    Wang SH; Chang JS; Hsiao JR; Yen YC; Jiang SS; Liu SH; Chen YL; Shen YY; Chang JY; Chen YW
    Oncogene; 2017 Mar; 36(11):1503-1515. PubMed ID: 27593938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dynamics of gene expression changes in a mouse model of oral tumorigenesis may help refine prevention and treatment strategies in patients with oral cancer.
    Foy JP; Tortereau A; Caulin C; Le Texier V; Lavergne E; Thomas E; Chabaud S; Perol D; Lachuer J; Lang W; Hong WK; Goudot P; Lippman SM; Bertolus C; Saintigny P
    Oncotarget; 2016 Jun; 7(24):35932-35945. PubMed ID: 27027432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of absent in melanoma 2 in oral squamous cell carcinoma contributes to tumor progression.
    Nakamura Y; Nakahata S; Kondo Y; Izumi A; Yamamoto K; Ichikawa T; Tamura T; Noumi K; Yamashita Y; Morishita K
    Biochem Biophys Res Commun; 2019 Jan; 509(1):82-88. PubMed ID: 30587341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.